December 04, 2023
Minneapolis Heart Institute Foundation Research Advances Understanding of Health Equity and Outcomes in Fourth-Trimester Care for Women
December 4, 2023 — The Minneapolis Heart Institute Foundation (MHIF), an internationally renowned cardiovascular…
Read More
The device would be the first clinical-grade, diagnostic wrist-worn device for long term Afib monitoring
December 01, 2023
Clinical Smartwatch Finds Success at Identifying Atrial Fibrillation
December 1, 2023 — As the use of wearable technology grows, smartwatches are marketed across the globe to consumers as…
Read More
Mount Sinai Fuster Heart Hospital is one of the world’s top four hospitals in Cardiology/Heart Surgery
December 01, 2023
Transcatheter Valve Replacement Procedures at the Mount Sinai Hospital Win Highest Rating from Society of Thoracic Surgeons
December 1, 2023 — For the third consecutive year, the Cardiac Catheterization Laboratory at The Mount Sinai Hospital…
Read More
Researchers have succeeded in restoring lost brain function in mouse models of stroke using small molecules that in the future could potentially be developed into a stroke recovery therapy.
December 01, 2023
New Study: Lost Brain Function Restored After Stroke
December 1, 2023 — Researchers have succeeded in restoring lost brain function in mouse models of stroke using small…
Read More
Innovative investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation
November 30, 2023
Johnson & Johnson MedTech Acquires Laminar, Inc.
November 30, 2023 — Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc…
Read More
Japan’s PMDA asked for further details on a number of elements included in BioCardia’s CardiAMP preclinical and clinical packages in order to gain approval.
November 30, 2023
BioCardia Shares Update from Japan PMDA Consultation on CardiAMP Autologous Cell Therapy for Ischemic Heart Failure; Foreign Data Expected to be Sufficient for Product Approval
November 30, 2023 —  BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of…
Read More
Data from all three patients in non-randomized cohort treated with DSR 2.0 indicate safe and effective maintenance of euvolemia without the need for loop diuretics, considerable benefit in cardiorenal status and dramatic improvement in diuretic response and loop diuretic requirements up to 11 weeks post DSR treatment
November 30, 2023
Sequana Medical Announces Positive Data from Non-randomized Cohort in US Phase 1/2a MOJAVE Study of DSR 2.0 for Treatment of Heart Failure
November 30, 2023 —  Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure…
Read More
Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the first patient enrollment in the PEERLESS II study
November 29, 2023
Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT)
November 29, 2023 —  Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of…
Read More
Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced completion of enrollment in the Indian clinical trial of the TRIA polymer surgical mitral heart valve.
November 29, 2023
Foldax Completes Enrollment in India Clinical Trial Evaluating TRIA Polymer Surgical Mitral Heart Valve
November 29, 2023 —  Foldax, Inc., a leader in the development of innovative, polymer heart valves, today announced…
Read More
Study to enroll 15 acute stroke patients across three U.S. sites
November 29, 2023
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
November 29, 2023 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention…
Read More
Impella Improves Survival and Heart Recovery
November 28, 2023
First Patient Enrolled in Abiomed’s RECOVER IV Randomized Controlled Trial of Impella as a Therapy for AMI Cardiogenic Shock
November 28, 2023 — Abiomed, part of Johnson & Johnson MedTech[1], announces the first patient in the world has…
Read More
New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman’s one to two-year risk for breast cancer
November 28, 2023
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
November 28, 2023 —  iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, will…
Read More
A Prespecified, Exploratory Analysis of Participants Reports Those with Higher Baseline Inflammation More Likely to Experience a Major Cardiovascular Event (MACE), Cardiovascular Death, and All-Cause Mortality Compared to Those with the Lowest Inflammation
November 27, 2023
Esperion Presents CLEAR Outcomes Analysis of Inflammation as Predictor of Cardiovascular Risk at American Heart Association Scientific Sessions 2023
November 27, 2023 — Esperion announced the presentation of results from a pre-specified, exploratory analysis of CLEAR…
Read More
First Phase 3 study of TNX-103 in PH-HFpEF patients to start in 4Q 2023 (The LEVEL Study)
November 27, 2023
Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023
November 27, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and…
Read More
November 22, 2023
Positive Results from ReVeRA Phase 2 Study of Etripamil Nasal Spray in AFib-RVR Presented by Milestone Pharmaceuticals during AHA 2023
November 24, 2023 — During the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA,…
Read More
A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems
November 22, 2023
Renal HeartSciences Announces Closing of License Agreements with the Icahn School of Medicine at Mount Sinai to Develop and Commercialize AI Cardiovascular Algorithms
November 22, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical…
Read More
Medinbox Link and Medinbox Air deliver cutting-edge technologies to enhance digital education and remote proctoring and support for cath labs and interventional rooms globally
November 22, 2023
Medinbox Advances Company Mission to Improve Access to Medical Education and Remote Support Around the World with Debut of New Product Suites for Interventional Ecosystem at TCT
November 22, 2023 — Medinbox, a leading global provider of video integrated collaboration systems for interventional…
Read More
The first clinical trial to challenge the routine implantation of a defibrillator in myocardial infarction survivors with heart failure has enrolled its first patient.
November 22, 2023
Trial to Prevent Sudden Death After a Heart Attack Enrolls First Patient
November 22, 2023 — The first clinical trial to challenge the routine implantation of a defibrillator in myocardial…
Read More
November 21, 2023
BridgeBio Pharma Presents Additional Clinical Outcomes Data from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases…
Read More
New partnership paves the way for early diagnosis and intervention to improve cardiovascular outcomes and quality of life for patients
November 21, 2023
AccurKardia Delivers its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions
November 21, 2023 — AccurKardia, an ECG-led diagnostics software company, announced a multi-year agreement with Lucem…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now